NewsBenzingaステランティス、第3四半期調整後EPSの損失が0.04ユーロから0.01ユーロに縮小 売上高は前年同期比1%増の376億ユーロ（372億ユーロ）に微増 ステランティス、第3四半期調整後EPSの損失が0.04ユーロから0.01ユーロに縮小 売上高は前年同期比1%増の376億ユーロ（372億ユーロ）に微増 Benzinga 2026.10.28 07:15 (GMT+0) Open on Benzinga Other news Bitcoin and Ethereum options worth nearly $11.7 billion in notional value to expire this Friday SK Hynix (SKHY) Stock Climbs In Pre-Market: Here’s What You Should Know Kevin O'Leary Warns Investors Could Get 'Slaughtered' by Ignoring Diversification, Shares His 5% Stock and 20% Sector Rule Materialise Affirms FY2026 Sales Guidance of $317.813M-$329.455M GSK FY2031 Revenue expected to be more than $53.204B vs $45.150B Est GSK Affirms FY2026 Adj EPS Guidance of $4.90-$5.00 vs $4.78 Est; Affirms FY2026 Sales Guidance of $44.754B vs $45.150B Est
Kevin O'Leary Warns Investors Could Get 'Slaughtered' by Ignoring Diversification, Shares His 5% Stock and 20% Sector Rule
GSK Affirms FY2026 Adj EPS Guidance of $4.90-$5.00 vs $4.78 Est; Affirms FY2026 Sales Guidance of $44.754B vs $45.150B Est
